期刊文献+

分化型甲状腺癌患者术后应用甲状腺素及停药对心血管的影响 被引量:1

The effects of Levothyronine theropy and Thyroxine withdrawal on cardiovascular function with differentiated thyroid carcinoma
下载PDF
导出
摘要 目的探讨分化型甲状腺癌患者术后左旋甲状腺素的应用和撤退心血管的影响。方法用化学发光法测定60例分化型甲状腺癌患者应用左旋甲状腺素形成TSH抑制(访视1)、停药后1周(访视2)、3周(访视3)及60例甲状腺功能正常的对照组血清FT3、FT4及TSH水平并查心脏彩超,动态血压监测。结果 DTC患者访视1、2时,TSH低于正常;访视3时,TSH明显高于正常。访视1、3和访视2相比均有夜间血压升高,"非杓型者"的比例明显增加。DTC患者访视3心率及心输出量明显降低,舒张功能明显减退。结论 DTC患者术后应用甲状腺素或停药对心血管均有不良影响。 Objective To evaluate the effects of levothyroxine therapy and thyroxine withdrawal on cardiovascular function in patients with differentiated thyroid carcinoma(DTC).Methods Sixty patients with DTC on levothyroxine therapy and 60 healthy controls were studied.We evaluated cardiac function before and 1 and 3 weeks after thyroxine withdrawal according to hormone levels,echocardiography and ambulatory blood pressure monitoring.Results When compared with visit 2,the percentage of non-dippers were increased during hypothyroidism and hyperthyroidism.Left ventricular mass and ejection fraction did not change during thyroxine withdrawal.Conclusion The levothyroxine therapy and thyroxine withdrawal of DTC have undesirable impact on cardiovascular system.
出处 《中国实用医药》 2011年第11期25-26,共2页 China Practical Medicine
关键词 分化型甲状腺癌 甲状腺素 心血管 Differentiated thyroid carcinoma(DTC) Thyroxine Cardiovascular
  • 相关文献

参考文献6

  • 1陈泽泉,罗全勇,陈立波,丁颖,余永利,陆汉魁.分化型甲状腺癌患者停用甲状腺素后TSH和FT_4水平的变化[J].上海交通大学学报(医学版),2008,28(1):39-41. 被引量:5
  • 2龚兰生,刘力生.血压昼夜变异及其临床意义[J].中华心血管病杂志,1994,22(5):323-324. 被引量:307
  • 3Hiroi Y,Kim HH,Ying H,et al.Rapid nongenomic actions of thyroid hormone.PNAS,2006,103:14104-14109.
  • 4Biondi B,Fazio S,Carella C,et al.Cardiac effects of long-term thyrotropin suppressive therapy with levothyroxine.Journal of Clinical Endocrinology & Metabolism,1993,77:334-338.
  • 5Crowley WF Jr,Ridgway EC,Bough EW,et al.Noninvasive evaluation of cardiac function in hypothyroidism,response to gradual thyroxine replacement.N Engl J Med,1977,296:1-6.
  • 6Vlzke H,Alte D,Drr M,et al.The association between subclinical hyper-thyroidism and blood pressure in a population-based study.JHypertens,2006,24:1947-53.

二级参考文献12

  • 1袁耿彪,匡安仁,黄蕤,彭伟凯,王全林,管昌田.分化型甲状腺癌术后随访中停用左旋甲状腺素2周的临床价值[J].中华核医学杂志,2006,26(3):152-155. 被引量:6
  • 2Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer [ J]. Thyroid, 2006,16 ( 2 ) : 109 - 142.
  • 3陈盛祖,张永学,黄刚,等.临床技术操作规范:核医学分册[M].北京:人民军医出版社,2004:178-181.
  • 4Vassilopoulou-Sellin R, Schuhz PN, Haynie TP. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after Initial radioactive Iodine therapy [ J ]. Cancer, 1996, 78 ( 3 ) : 493 - 501.
  • 5Medina DL, Santisteban P. Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems [ J ]. Eur Endocrinol,2000,143 ( 2 ) : 161 - 178.
  • 6Kimura T, Van Keymeulen A, Golstein J, et al. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models[J]. Endocr Rev, 2001,22 (5) :631 - 656.
  • 7Rivas M, Santisteban P. TSH-activated signaling pathways in thyroid tumorigenesis[ J]. Mol Cell Endoerinol,2003, 213 ( 1 ) :31 -45.
  • 8Durski JM, Weigel ILl, McDougall IR. Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer[J]. Nucl Med Commun,2000,21(6) : 521 -528.
  • 9Sanchez R, Espinosa-de-los-Monteros AL, Mendoza V, et al. Adequate thyroid-stimulating hormone levels after levothyroxine discontinuation in the follow-up of patients with well-differentiated thyroid carcinoma[ J]. Arch Med Res, 2002, 33(5):478-481.
  • 10Tagay S, Herpertz S, Langkafel M, et al. Heahh-related quality of life, depression and anxiety in thyroid cancer patients[ J]. Qual Life Res ,2006,15 (4) :695 - 703.

共引文献310

同被引文献11

引证文献1

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部